Sera Prognostics develops simple blood tests predictive of preterm birth, preeclampsia and other pregnancy complications.
As a specialty contract research organization (CRO), Numira Biosciences has set the bar in discovery pharmacology, high-resolution imaging, histology and analysis of small animal specimens. We provide researchers with quantifiable, visible evidence of disease progression, drug efficacy and drug side effects in their animal models.
TechniScan Medical Systems (TMS) is a privately held medical device company engaged in the development and commercialization of a revolutionary ultrasound imaging system, UltraSound CTTM (USCTTM). TMS imaging system is designed to provide physicians with a new, non-invasive, diagnostic imaging tool that will provide detailed information about the anatomy (i.e. physical structures within the breast) and pathology (i.e. bulk tissue properties).
Merit Medical Systems, Inc. (Nasdaq: MMSI) is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures.
M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's proprietary hydrogel technology, M-Biotech focuses specifically on the development of glucose biosensors for continuous monitoring of glucose levels in diabetic patients.
Lipocine Inc. was founded in 1997 by distinguished drug delivery professionals, Drs. William Higuchi (former Co-founder and Chairman of TheraTech, a drug delivery company) and Mahesh Patel (Pharmacia and Upjohn). The company has numerous issued patents and several pending patent applications in most major markets. The company is headquartered in Salt Lake City and has its labs and business offices in research park, a technology hub close to University of Utah.
Founded in 2005, Great Basin Corporation is dedicated to developing simple yet powerful point-of-care technology and products that improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing.
CardioRisk Laboratories is a medical company specializing in heart attack and stroke prevention through a proprietary CIMT ultrasound scan of the carotid artery. The test is painless, non-invasive, requires no disrobing, and can be completed in 10 minutes. Unlike other tests for heart attack and stroke, the CardioRisk IMT test sounds out the silent and deadly plaque in its earliest stages allowing doctors the time to treat the disease medically instead of surgically. It is reproducible enough to help physicians track the efficacy of their treatment at the individual patient level.
Axial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is the first company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices.
AnzenBio manufactures and markets innovative, field-deployable electrochemical systems for pathogen detection and for the quantitative analysis of DNA in scientific and commercial research settings. Founded in 2003, AnzenBio has established itself as a pioneer in the development of portable, field-deployable pathogen detection and DNA extraction and amplification products.